General
Preferred name
ERUCIC ACID
Synonyms
Prifac 2990 ()
13(Z)-Docosenoic Acid ()
cis-13-docosenoic acid ()
13(Z)-Docosenoic Acid (sodium salt) ()
P&D ID
PD020550
CAS
14488-85-8
112-86-7
Tags
available
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Increased levels of erucic acid (22:1n9) have been found in the red blood cell membranes of autistic subjects with developmental regression (PMID: 16581239 ). Erucic acid (13(Z)-Docosenoic Acid) is broken down long-chain acyl-coenzyme A (CoA) dehydrogenase, which is produced in the liver. This enzyme breaks this long chain fatty acid into shorter-chain fatty acids. human infants have relatively low amounts of this enzyme and because of this, babies should not be given foods high in erucic acid. Erucic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism. (TargetMol Bioactive Compound Library)
Compound Sets
4
Cayman Chemical Bioactives
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
44
Properties
(calculated by RDKit )
Molecular Weight
338.32
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
1
Rotatable Bonds
19
Ring Count
0
Aromatic Ring Count
0
cLogP
7.67
TPSA
37.3
Fraction CSP3
0.86
Chiral centers
0.0
Largest ring
0.0
QED
0.19
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Endogenous Metabolite
Human Endogenous Metabolite
PI3K
Pathway
Metabolic Enzyme/Protease
PI3K/Akt/mTOR
Metabolism
PI3K/Akt/mTOR signaling
Source data